Jay Skyler is listed as a director on 2 SEC Form D filings by 1 issuer between Mar 2019 and Jan 2020: INTARCIA THERAPEUTICS, INC (Boston, MA — biotechnology — 2019–2020; $524.6M reported sold to 90 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Bob Kerrey (2 shared filings), Bryan Roberts (2 shared filings), Fred Fiedorek (2 shared filings), Gino Santini (2 shared filings), Jim Rosenthal (2 shared filings) and 12 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jay. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Jay Skyler and found 6 differences: Offering amount changed between filings; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.